This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Study of Chemotherapy With Pembrolizumab (MK-3475)...
Clinical trial

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

Read time: 1 mins
Last updated:14th Feb 2021
Status: Recruiting
Identifier: NCT03740165
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest